El Parc Taulí begins treatment with Kaftrio for children between 2 and 5 years old with Cystic Fibrosis
This medicine, which until now could only be administered from the age of 6, marks a before and after in the lives of patients read more
Cystic fibrosis
Parc Taulí cares for around 85 patients with Cystic Fibrosis
On World Cystic Fibrosis Day, the coordinator of the CF Unit at Parc Taulí has insisted on the importance of research to provide new drugs to the 30-35% of patients who still do not have treatment read more
The Daniel Bravo Andreu Private Foundation donates 1.100 home spirometers to Parc Taulí, Vall d'Hebron and Sant Joan de Déu to improve the monitoring of respiratory pathologies
Home spirometry is the most important test to assess respiratory capacity, detect pulmonary exacerbations and evaluate the response to treatment in patients with respiratory pathologies. read more
The Cystic Fibrosis Unit of Parc Taulí, accredited as a reference unit with a degree of excellence by the Spanish CF Society
Parc Taulí is one of the three reference centers in Cystic Fibrosis in Catalonia, along with the Vall d'Hebron and Sant Joan de Déu hospitals in Barcelona. This center treats 85 patients diagnosed with CF, children and adults. This accreditation means the recognition of a multidisciplinary team that works to improve the quality of life of people with CF. read more
Parc Taulí will administer Kaftrio®, the revolutionary treatment that will change the lives of patients with Cystic Fibrosis
Parc Taulí, one of the three leading centers in Cystic Fibrosis in Catalonia, together with the Vall d'Hebron and Sant Joan de Déu hospitals in Barcelona, will administer the Kaftrio® drug. Four patients from Parc Taulí have participated in the clinical trial of this treatment. read more